[1] |
DASARI A, SHEN C, HALPERIN D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States[J]. JAMA Oncol, 2017, 3(10): 1335-1342.
doi: 10.1001/jamaoncol.2017.0589
pmid: 28448665
|
[2] |
FAN J H, ZHANG Y Q, SHI S S, et al. A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in China[J]. Oncotarget, 2017, 8(42): 71699-71708.
doi: 10.18632/oncotarget.17599
|
[3] |
ITO T, IGARASHI H, NAKAMURA K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis[J]. J Gastroenterol, 2015, 50(1): 58-64.
doi: 10.1007/s00535-014-0934-2
pmid: 24499825
|
[4] |
NAGTEGAAL I D, ODZE R D, KLIMSTRA D, et al. The 2019 WHO classification of tumours of the digestive system[J]. Histopathology, 2020, 76(2): 182-188.
doi: 10.1111/his.13975
pmid: 31433515
|
[5] |
刘文生, 许文彦, 吉顺荣, 等. 腹腔镜胰体尾切除治疗神经内分泌肿瘤单中心研究[J]. 腹腔镜外科杂志, 2019, 24(10): 766-769.
|
|
LIU W S, XU W Y, JI S R, et al. A single institution study of laparoscopic pancreatectomy for pancreatic neuroendocrine tumor in body and tail of pancreas[J]. J Laparosc Surg, 2019, 24(10): 766-769.
|
[6] |
王于, 陈洁. 胰腺神经内分泌肿瘤复杂肝转移的介入及药物治疗策略[J]. 协和医学杂志, 2020, 11(4): 389-394.
|
|
WANG Y, CHEN J. The management strategies of interventional therapy and drug therapy of complicated pancreatic neuroendocrine neoplasms with liver metastases[J]. Med J Peking Union Med Coll Hosp, 2020, 11(4): 389-394.
|
[7] |
DINDO D, DEMARTINES N, CLAVIEN P A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg, 2004, 240(2): 205-213.
doi: 10.1097/01.sla.0000133083.54934.ae
pmid: 15273542
|
[8] |
BASSI C, MARCHEGIANI G, DERVENIS C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after[J]. Surgery, 2017, 161(3): 584-591.
doi: 10.1016/j.surg.2016.11.014
|
[9] |
THOMASCHEWSKI M, NEEFF H, KECK T, et al. Is there any role for minimally invasive surgery in NET?[J]. Rev Endocr Metab Disord, 2017, 18(4): 443-457.
doi: 10.1007/s11154-017-9436-x
|
[10] |
VAN NIEUWENHOVE Y, DELVAUX G. Laparoscopic management of neuroendocrine tumours of the pancreas[J]. Acta Chir Belg, 1999, 99(5): 249-252.
pmid: 10582077
|
[11] |
MELVIN W S, NEEDLEMAN B J, KRAUSE K R, et al. Computer-enhanced robotic telesurgery. Initial experience in foregut surgery[J]. Surg Endosc, 2002, 16(12): 1790-1792.
pmid: 12239646
|
[12] |
ZIOGAS I A, SCHMITZ R, MORIS D, et al. The role of surgery for pancreatic neuroendocrine tumors[J]. Anticancer Res, 2022, 42(2): 629-639.
doi: 10.21873/anticanres.15520
pmid: 35093860
|
[13] |
HAN S H, HAN I W, HEO J S, et al. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study[J]. Surg Endosc, 2018, 32(1): 443-449.
doi: 10.1007/s00464-017-5702-y
pmid: 28664429
|
[14] |
DRYMOUSIS P, RAPTIS D A, SPALDING D, et al. Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis[J]. HPB (Oxford), 2014, 16(5): 397-406.
doi: 10.1111/hpb.12162
|
[15] |
TAN H L, TEO R Y A, SYN N L, et al. Minimally invasive versus open pancreatectomies for pancreatic neuroendocrine neoplasms: a propensity-score-matched study[J]. World J Surg, 2020, 44(9): 3043-3051.
doi: 10.1007/s00268-020-05582-3
|
[16] |
HAUGVIK S P, MARANGOS I P, RØSOK B I, et al. Long-term outcome of laparoscopic surgery for pancreatic neuroendocrine tumors[J]. World J Surg, 2013, 37(3): 582-590.
doi: 10.1007/s00268-012-1893-5
|
[17] |
CABA MOLINA D, LAMBRETON F, ARRANGOIZ MAJUL R. Trends in robotic pancreaticoduodenectomy and distal pancreatectomy[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(2): 147-151.
doi: 10.1089/lap.2018.0421
pmid: 30222522
|
[18] |
赵之明, 尹注增, 姜楠, 等. 机器人与腹腔镜肿瘤剜除术治疗胰头部胰岛素瘤的对比研究[J]. 腹腔镜外科杂志, 2020, 25(4): 241-244.
|
|
ZHAO Z M, YIN Z Z, JIANG N, et al. A comparative study of robotic and laparoscopic tumor enucleation in the treatment of pancreatic head insulinoma[J]. J Laparosc Surg, 2020, 25(4): 241-244.
|
[19] |
ZHANG J Q, JIN J B, CHEN S, et al. Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?[J]. Oncotarget, 2017, 8(20): 33872-33883.
doi: 10.18632/oncotarget.17513
pmid: 28477012
|
[20] |
周雨, 陈洛海, 李德智, 等. 小非功能性胰腺神经内分泌肿瘤的预后因素[J]. 中华消化杂志, 2018(3): 187-191.
|
|
ZHOU Y, CHEN L H, LI D Z, et al. Prognostic factors of small non-functional pancreatic neuroendocrine tumors[J]. Chin J Dig, 2018(3): 187-191.
|
[21] |
姜佳霖, 吴文铭, 赵玉沛. 微小胰腺神经内分泌肿瘤的诊疗进展[J]. 中华外科杂志, 2018(12): 951-956.
|
|
JIANG J L, WU W M, ZHAO Y P. Current diagnosis and treatment progress of small pancreatic neuroendocrine neoplasm[J]. Chin J Surg, 2018(12): 951-956.
|
[22] |
FALCONI M, ERIKSSON B, KALTSAS G, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors[J]. Neuroendocrinology, 2016, 103(2): 153-171.
doi: 10.1159/000443171
pmid: 26742109
|
[23] |
SHAH M H, GOLDNER W S, BENSON A B, et al. Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021, 19(7): 839-868.
doi: 10.6004/jnccn.2021.0032
|
[24] |
YANG G, JI M, CHEN J, et al. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET)[J]. Int J Oncol, 2017, 50(2): 567-574.
doi: 10.3892/ijo.2016.3826
pmid: 28035372
|